TRIM56 Promotes Antiviral Responses Downstream of TLR4

Area of Science:

• Immunology
• Molecular Biology
• Virology

Background:

• Tripartite-motif containing 56 (TRIM56) is known to regulate Toll-like receptor 3 (TLR3) signaling.
• The role of TRIM56 in other Toll-like receptor (TLR) pathways, particularly in innate antiviral immunity, remains largely unexplored.

Purpose of the Study:

• To investigate whether TRIM56 modulates other TLR pathways, specifically TLR4, in the context of innate antiviral immunity.
• To elucidate the mechanism by which TRIM56 influences TLR4 signaling and its downstream effects on antiviral responses.

Main Methods:

• Ectopic expression of TRIM56 in HEK293-TLR4-MD2-CD14 cells to assess activation of IRF3 and NF-κB dependent promoters upon lipopolysaccharide (LPS) stimulation.
• Enforced expression and depletion of TRIM56 in bone marrow-derived macrophages to evaluate LPS-induced expression of interferon-beta (IFN-β) and IFN-stimulated genes (ISGs).
• Assessment of the establishment of an antiviral state in response to TRIM56 modulation and LPS stimulation.

Main Results:

• Ectopic TRIM56 expression augmented IRF3-dependent promoter activation via the TLR4-TRIF axis, without affecting the MYD88 arm.
• Enforced TRIM56 expression enhanced LPS-induced IFN-β and ISG expression, promoting an antiviral state in macrophages.
• Depletion of endogenous TRIM56 impaired LPS-induced antiviral gene expression and cellular antiviral defense.

Conclusions:

• TRIM56 specifically promotes immune signaling through the TLR4-TRIF pathway, enhancing innate antiviral immunity.
• TRIM56 plays a critical role in endogenous antiviral responses, as evidenced by impaired immunity upon its depletion.
• Findings suggest TRIM56's potential as a therapeutic target for immunotherapies, particularly for viral infections.